Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by A.M. Frederickson
Pcn169 - A Flexible Open-Source Cost-Effectiveness Model for Metastatic Egfr+ Non-Small Cell Lung Cancer
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pcn34 - Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Non-Squamous NSCLC – A Network Meta-Analysis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Third Generation EGFR TKI Landscape for Metastatic EGFR Mutant Non-Small Cell Lung Cancer (NSCLC)
Expert Review of Anticancer Therapy
Oncology
Pharmacology
A Systematic Review of the Cost-Effectiveness of Targeted Therapies for Metastatic Non-Small Cell Lung Cancer (NSCLC)
BMC Pulmonary Medicine
Pulmonary
Respiratory Medicine
P043 Cost-Effectiveness Analysis of Different Sequences of Osimertinib Administration for EGFR-Mutated Non-Small-Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Pcn134 - Use of Liquid Biopsy in Metastatic Non-Small Cell Lung Cancer With Egfr Mutation: A Cost Consequence Analysis.
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Cost‐Effectiveness of Osimertinib in Treating Newly Diagnosed, Advanced EGFR‐Mutation‐Positive Non‐Small Cell Lung Cancer
Oncologist
Cancer Research
Medicine
Oncology
Cost-Effectiveness Analysis of Pembrolizumab Plus Chemotherapy for Previously Untreated Metastatic Non-Small Cell Lung Cancer in the USA
BMJ Open
Medicine
EGFR Mutations Status for Non-Small-Cell Lung Cancer Patients
Sveikatos mokslai
Influence of EGFR Mutational Status on Metastatic Behavior in Non Squamous Non Small Cell Lung Cancer
Oncotarget
Oncology
Effectiveness of First-Line Treatments in Metastatic Squamous Non-Small-Cell Lung Cancer
Current Oncology
Oncology